Sanofi India liquidity ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Dec 2025FY25Dec 2024FY24Dec 2023FY23Dec 2022FY22 and earlierAlpha Plus
12.62×————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.88×1.88×1.76×1.91×2.18×
1.24×1.24×1.06×0.89×1.62×
2632632843931,005
430430545595870
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFI₹3,189.50

Sanofi India Limited

· Pharma & Health
₹ CrorePeersSENORESINNOVACAPPGHLMOREPENLABIOLCPSANOFICONRFDCORCHPHARMAMcap ₹7,336 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/12/2022
FY24
31/12/2023
FY25
31/12/2024
FY26
31/12/2025
Last 12M
30/09/2026
Altman Z-Score (Other Equity as RE)————12.62
Current Ratio2.181.911.761.881.88
Quick Ratio1.620.891.061.241.24
Cash, Equiv & ST Investments1,004.9392.9283.8262.9262.9
Working Capital869.6595.0545.0430.4430.4
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.